JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1998) 159, 9-14       DOI: 10.1677/joe.0.1590009
© 1998 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobori, H
Right arrow Articles by Saruta, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobori, H
Right arrow Articles by Saruta, T
Journal of Endocrinology, Vol 159, Issue 1, 9-14
Copyright © 1998 by Society for Endocrinology


Articles

Mechanism of hyperthyroidism-induced renal hypertrophy in rats

H Kobori, A Ichihara, Y Miyashita, M Hayashi, and T Saruta


It is well known that renal hypertrophy is induced by hyperthyroidism; however, the mechanism is not fully understood. We recently reported that cardiac hypertrophy in hyperthyroidism is mediated by enhanced cardiac expression of renin mRNA. The present study addresses the hypothesis that renal hypertrophy in hyperthyroidism is mediated by amplification of renal expression of renin mRNA. Twenty Sprague-Dawley rats were divided into control (n=5) and hyperthyroid groups by daily intraperitoneal injections of saline vehicle or thyroxine. The hyperthyroid group was subdivided further into hyperthyroid-vehicle (n=5), hyperthyroid-losartan (n=5), and hyperthyroid-nicardipine (n=5) groups by daily intraperitoneal injections of saline vehicle, losartan, or nicardipine. All rats were killed at 4 weeks, and the blood and kidneys were collected. The kidney-to-body weight ratio increased in the hyperthyroid groups (+34%). Radioimmunoassays and reverse transcriptase-polymerase chain reaction revealed increased renal renin (+91%) and angiotensin II (+65%) levels and enhanced renal renin mRNA expression (+113%) in the hyperthyroid groups. Losartan and nicardipine decreased systolic blood pressure to the same extent, but only losartan caused regression of thyroxine-induced renal hypertrophy. These results suggest that thyroid hormone activates the intrarenal renin-angiotensin system via enhancement of renal renin mRNA expression, which then leads to renal hypertrophy.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
N. Schliebe, R. Strotmann, K. Busse, D. Mitschke, H. Biebermann, L. Schomburg, J. Kohrle, J. Bar, H. Rompler, J. Wess, et al.
V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1177 - F1190.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. Vargas, J. M. Moreno, I. Rodriguez-Gomez, R. Wangensteen, A. Osuna, M. Alvarez-Guerra, and J. Garcia-Estan
Vascular and renal function in experimental thyroid disorders
Eur. J. Endocrinol., February 1, 2006; 154(2): 197 - 212.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Kobori, M. Hayashi, and T. Saruta
Thyroid Hormone Stimulates Renin Gene Expression Through the Thyroid Hormone Response Element
Hypertension, January 1, 2001; 37(1): 99 - 104.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Cauvi, C. Penel, M. C. Nlend, N. Venot, C. Allasia, and O. Chabaud
Regulation of thyroid cell volumes and fluid transport: opposite effects of TSH and iodide on cultured cells
Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E546 - E553.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society for Endocrinology.